Quantcast
Last updated on April 23, 2014 at 11:05 EDT

Latest Low-density lipoprotein Stories

2014-04-17 08:28:21

New Yorkers Can Now Benefit from a Personalized Cardiovascular Disease Wellness Program FRAMINGHAM, Mass., April 17, 2014 /PRNewswire/ -- Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics into personalized nutrition and lifestyle programs for patients with or at risk for heart disease, today announced that the company can serve patients from all 50 states now that it has successfully completed the New York State Department of Health (NYSDOH)...

2014-04-10 23:24:53

Health Nutrition News explains why lowering triglycerides are important for heart health and discusses how to lower triglycerides using the right kind of omega-3 supplements. Boston, MA (PRWEB) April 10, 2014 Health Nutrition News has a new video in which they discuss triglycerides (TG), how they are important to human life, and are the main form of fat in the body. When the body has extra triglycerides, they are stored in different places, such as the hips and belly, in case they are...

2014-04-10 11:17:19

Should dental health now be considered a marker of coronary heart disease? Periodontal disorders such as tooth loss and gingivitis have been identified as a potential risk marker for cardiovascular disease in a large study reported today. More than 15,000 patients with chronic coronary heart disease provided information on their dental health, with results showing that indicators of periodontal disease (fewer remaining teeth, gum bleeding) were common in this patient group and associated...

2014-04-08 16:23:06

WOODBRIDGE, ON, April 8, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced today that it has granted previously reserved stock options to certain of its directors, officers, employees and consultants in recognition of their contributions made in 2013. Options to acquire a total of 4,176,000 common shares of the Company were granted in...

Beans Help Reduce LDL Cholesterol And Lower Risk Of Cardiovascular Disease
2014-04-08 05:21:34

redOrbit Staff & Wire Reports - Your Universe Online One serving of beans, peas, chickpeas or lentils per day can significantly reduce a person’s so-called bad cholesterol and lower his or her risk of cardiovascular disease, according to new research appearing in Monday’s edition of the Canadian Medical Association Journal. Unfortunately, most people living in North American currently consume less than half that amount and would have to drastically increase their daily servings...

2014-04-02 08:33:03

Researchers Continue to Reveal Benefits to Consuming Anthocyanin-Rich Foods like Strawberries WATSONVILLE, Calif., April 2, 2014 /PRNewswire-USNewswire/ -- According to new published research in the Journal of Nutrition, consumption of anthocyanin-rich foods such as strawberries may play an important role in lowering cholesterol and other risk factors for cardiovascular disease. To evaluate the effects of strawberries on cardiovascular risk factors, researchers at Oklahoma State University...

2014-04-02 08:26:30

First and Goal Campaign encourages small, achievable accomplishments in cholesterol management NEW YORK, April 2, 2014 /PRNewswire/ -- Kowa Pharmaceuticals America, Inc. today announced a partnership with Kurt Warner, Super Bowl winner and two-time NFL MVP, and his wife Brenda, to launch First and Goal, a national education initiative to help people prioritize heart health. The campaign encourages the 71 million Americans living with high cholesterol to develop a personalized game plan to get...

2014-04-01 23:01:39

Susquehanna Health (SH) Cardiologist Dr. Liran Blum said new guidelines established by the American College of Cardiology (ACC) and American Heart Association (AHA) regarding the recommended use of cholesterol-reducing drugs called statins are appropriate and should be viewed primarily as guidelines when determining a patient’s course of treatment for the prevention of cardiovascular events such as heart attacks or strokes. “I think the guidelines and the recent [Duke University] study...

2014-04-01 23:01:23

The Firm is investigating Lipitor lawsuits on behalf of patients who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin. New York, New York (PRWEB) April 01, 2014 As Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) filed on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin continue to mount in federal court, Bernstein Liebhard LLP notes the release of two new studies which suggest...

2014-04-01 08:28:50

New investigational PCSK9 inhibitor shown to significantly reduce LDL-C among Japanese patients BRIDGEWATER, N.J. and TARRYTOWN, N.Y., April 1, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the first Phase 2 study with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), in Japanese patients met its primary endpoint. The results...